Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHospital Clinic of Barcelona
About this trial
The aim of the study is to evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and obstructive sleep apnea (OSA)
Eligibility criteria
Qualifiers
Age >18 years
Diagnosis of severe uncontrolled asthma according to the criteria of the Spanish Asthma Management Guide (GEMA) or the Global Initiative for Asthma (GINA) and no hospitalizations the month prior to inclusion in the study.
Apnea hypopnea rate greater than or equal to 15/hour
Punctuation in the Epworth Sleepiness Scale ≤10
Disqualifiers
Previous treatment with CPAP
Patient with central sleep apnea or Cheyne-Stokes respiration
Other sleep disorders: narcolepsy, restless leg syndrome, chronic insomnia,
Resistant hypertension
Trial design
Treatments tested in this trial
- CPAP treatment
- Hygienic and dietary advice
Treatment groups
138 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov